New Anti-Amyloid Therapies Revolutionize Alzheimer's Diagnosis and Treatment Protocols
Rapid Read

New Anti-Amyloid Therapies Revolutionize Alzheimer's Diagnosis and Treatment Protocols

What's Happening? The introduction of new anti-amyloid therapies, lecanemab in 2023 and donanemab in 2024, has fundamentally transformed the approach to Alzheimer's disease management. Historically, Alzheimer's treatment focused on symptomatic relief, with MRI and CT scans primarily used to rule out
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.